NAYA: NAYA Biosciences Inc. Company Cash Volume

NAYA (NAYA Biosciences Inc.) - company brandmark

NAYA Biosciences automates the development of cancer antibodies using AI and robotics, creating a defensive asset independent of macroeconomic trends. The company's cash position demonstrates financial stability, with the figure standing at 0.00. Management is focused on capital raising and scientific breakthroughs to capitalize on its innovative treatment platform.

Company Cash Reserve: NAYA Bio (NAYA) for 07/04/2022 - 04/28/2025

Metric breakdowns and analytics for NAYA Biosciences Inc. (NAYA)

- stock quotes and analyst forecast:
Basic company analysis:NAYA Biosciences Inc
Brand item of nayabiosciences.com

For NAYA Biosciences, the company's cash dynamics reflect the viability of the venture model for developing oncology assets. This indicator aggregates all highly liquid funds and equivalents available for operational management. The metric measures the business's margin of safety, allowing for the calculation of the burn rate until the next funding round. Amidst the formation of the management structure, this reserve is critical for completing early-stage clinical trials. Liquidity here serves as the primary guarantee of the company's survival in the absence of stable revenue.

Competitors of NAYA Biosciences (NAYA)

Company Cash Volume ONC|HALO - Company Cash Reserve|Revolution Medicines - Company Cash on Hand|Company Cash Volume Ascentage Pharma AAPG|CGON - Company Cash Funds|Company Total Cash Volume URGN|BCAX: Company Cash Volume|PSNL - Company Liquid Assets|ERAS (Erasca Inc) - Company Cash Volume|Company Cash Reserve Delcath Systems Inc DCTH|Company Cash Funds YmAbs (YMAB)|Company Liquid Assets Aura Bio|Company Cash Volume CADL (Candel Therapeutics Inc.)|accuray.com (ARAY) - Company Cash Reserve|SELLAS Life Sciences Group - Company Cash Volume|ACTU - Company Cash Volume|CTOR: Company Cash Volume|Company Cash Reserve TuHURA (HURA)|TARA (Protara Therapeutics Inc) - Company Cash Volume|Fate Therapeutics, Inc. (FATE) - Company Liquid Assets|Company Cash on Hand WHWK (Aadi Bioscience, Inc.)|Company Liquid Assets TScan Therapeutics, Inc.|Company Cash Volume CSBR (Champions Oncology Corp)|Company Total Cash Amount XBIT (XBiotech USA)|CVM - Company Cash Funds|Company Cash Balance OSTX (ostherapies.com)|Radiopharm Theranostics Ltd (RADX) - Company Cash Funds|ARTV: Company Total Cash Amount|ANL (adlainortye.com) - Company Cash Volume|VERU: Company Cash Balance|Company Cash on Hand TPST (Tempest Tx)|Company Cash on Hand Xilio XLO|Company Cash Volume RENB (Renovaro)|Company Cash Volume Mural Bio MURA|Kairos Pharma Ltd - Company Cash Volume|OnKure Therapeutics (OKUR) - Company Cash on Hand|GDTC: Company Cash Volume|Curis Inc. - Company Cash Balance|Company Cash Funds apollomicsinc.com|THAR: Company Cash Balance|Company Cash Funds Advanced Biomed Corp (ADVB)|GNPX (Genprex, Inc) - Company Cash Balance|Company Cash Volume CLDI (Calidi Biotherapeutics)|sunshinebiopharma.com (SBFM) - Company Cash Reserve|Xenetic Bio - Company Cash Volume|SLRX (Salarius Pharmaceuticals, Inc.) - Company Cash and Cash Equivalents|PPBT: Company Cash Volume|Company Cash on Hand American Oncology Network Inc|BGNE (beigene.com) - Company Cash Volume|Company Cash and Cash Equivalents CKPT (Checkpoint Therapeutics)|Company Cash on Hand ELEV (Elevation Oncology Inc.)|iCAD - Company Cash and Cash Equivalents|Ikena Oncology Inc. - Company Cash on Hand|Notable Labs Corp (NTBL) - Company Cash Reserve|VIRX: Company Cash on Hand|Company Cash Reserve morphosys.com|Ascentage Pharma (AAPGV) - Company Cash Funds